Associated Papers
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.
Yao M et al.
World Journal of Gastroenterology, 2023
Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
Joshi PR et al.
Molecules (basel, Switzerland), 2020
Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency.
Motlagh Scholle L et al.
International Journal of Molecular Sciences, 2019
Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
Isackson PJ et al.
Molecular Genetics and Metabolism, 2006
Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.
Sigauke E et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2003
A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency.
Deschauer M et al.
Molecular Genetics and Metabolism, 2003
A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.
Deeb SS et al.
American Journal of Human Genetics, 1990
Select a paper to view details